UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

The Journal of experimental medicine, 2006-03, Vol.203 (3), p.513-518

2006

Volltextzugriff (PDF)

Low-dose Immune Tolerance Induction in Hemophilia: A Single-Center Experience

Journal of pediatric hematology/oncology, 2019-08, Vol.41 (6), p.e355-e358

2019

Volltextzugriff (PDF)

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-07, Vol.15 (4), p.904-910

2009

Volltextzugriff (PDF)

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.752-759

2009

Volltextzugriff (PDF)

Are hemostasis and thrombosis two sides of the same coin?

The Journal of experimental medicine, 2006-03, Vol.203 (3), p.493-495

Colman, Robert W

2006

Volltextzugriff (PDF)

Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre

Journal of thrombosis and thrombolysis, 2014-07, Vol.38 (1), p.92-97

2014

Volltextzugriff (PDF)

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-09, Vol.15 (5), p.1065-1073

2009

Volltextzugriff (PDF)

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.760-765

2009

Volltextzugriff (PDF)

Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy

Medical science monitor, 2009-06, Vol.15 (6), p.CS105-CS111

2009

Volltextzugriff (PDF)

Home treatment with bypassing products in inhibitor patients: a 7.5-year experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.727-732

2009

Volltextzugriff (PDF)

Side-effects and venous access issues with immune tolerance therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-03, Vol.15 (2), p.494-500

CARCAO, MANUEL D.

2009

Volltextzugriff (PDF)

Surgery in Patients With Hemophilia and Inhibitors: A Review of the Norwegian Experience With FEIBA

Seminars in hematology, 2006-04, Vol.43 (2), p.S18-S21

Tjønnfjord, Geir E.

2006

Volltextzugriff (PDF)

Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-07, Vol.13 (4), p.357-360

2007

Volltextzugriff (PDF)

Registered nurses for the home treatment of children with haemophilia who have developed inhibitors: a case report

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.820-822

2009

Volltextzugriff (PDF)

HELLP syndrome is a life-threatening pregnancy complication. A specific coagulation factor therapy is now possible

Läkartidningen, 1999-03, Vol.96 (9), p.1025-1030

1999

Volltextzugriff (PDF)

Management of bleeding disorders in children

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (s2), p.15-23

2012

Volltextzugriff (PDF)

Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels

Thrombosis and haemostasis, 2014-06, Vol.111 (6), p.1133-1140

2014

Volltextzugriff (PDF)

Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers

Journal of thrombosis and haemostasis, 2018-01, Vol.16 (1), p.54-64

2018

Volltextzugriff (PDF)

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

The New England journal of medicine, 2015-01, Vol.372 (3), p.232-240

2015

Volltextzugriff (PDF)

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban

Thrombosis and haemostasis, 2017-02, Vol.117 (2), p.238-245

2017

Volltextzugriff (PDF)

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Thrombosis and haemostasis, 2013-08, Vol.110 (2), p.283-294

2013

Volltextzugriff (PDF)

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Chest, 2012-02, Vol.141 (2 Suppl), p.e737S-e801S

2012

Volltextzugriff (PDF)

Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate

Circulation (New York, N.Y.), 2015-01, Vol.131 (1), p.82-90

2015

Volltextzugriff (PDF)

Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies

Journal of thrombosis and haemostasis, 2017-05, Vol.15 (5), p.835-847

2017

Volltextzugriff (PDF)

Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review

Thrombosis research, 2015-07, Vol.136 (1), p.7-12

2015

Volltextzugriff (PDF)

1 – 25 von 1.798

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.707)
Mit Volltextzugriff
(1.166)

Publikationsform

Artikel
(1.797)
magazinearticle
(1)

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.577)
Science & Technology
(1.568)
Life Sciences & Biomedicine
(1.548)
Male
(1.028)
Biological And Medical Sciences
(820)
Medical Sciences
(797)
Hematology
(780)
Female
(778)
Cardiovascular System & Cardiology
(720)
Middle Aged
(602)
Peripheral Vascular Disease
(580)
Blood Coagulation - Drug Effects
(545)
Anticoagulants - Administration & Dosage
(544)
Adult
(526)
Pharmacology. Drug Treatments
(493)
Aged
(488)
Blood. Blood Coagulation. Reticuloendothelial System
(440)
Administration, Oral
(410)
Animals
(394)
Time Factors
(390)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.786)
Journals@Ovid Full Text
(1.074)
IngentaConnect
(783)
Free E-Journal (出版社公開部分のみ）
(607)
IngentaConnect Journals
(491)
NUS Single-Journal Subscriptions
(485)
ScienceDirect
(341)
Wiley Online Library
(319)
Wiley Online Library Full Collection 2018
(291)
Thieme Connect Journals
(284)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(261)
Springer Online Journals
(142)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(85)
Oxford Journals
(48)
Taylor & Francis Journals
(48)
Oxford Journals 2020 Medicine
(44)
Taylor & Francis
(41)
SAGE Journals
(40)
Taylor & Francis Journals Complete
(31)
Nexis Uni
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

Low-dose Immune Tolerance Induction in Hemophilia: A Single-Center Experience

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic

Are hemostasis and thrombosis two sides of the same coin?

Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres

Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy

Home treatment with bypassing products in inhibitor patients: a 7.5-year experience

Side-effects and venous access issues with immune tolerance therapy

Surgery in Patients With Hemophilia and Inhibitors: A Review of the Norwegian Experience With FEIBA

Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients

Registered nurses for the home treatment of children with haemophilia who have developed inhibitors: a case report

HELLP syndrome is a life-threatening pregnancy complication. A specific coagulation factor therapy is now possible

Management of bleeding disorders in children

Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels

Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate

Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies

Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review

Suchergebnisse filtern